New Key Statistics Module, Z-Score and F-Score
OTCPK:MAYNF Key Ratios
| Market Cap $ M | 227.89 |
| Enterprise Value $ M | 154.53 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.82 |
| Price/Sales | 0.94 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 258.00 |
| EPS (TTM) $ | -1.46 |
| Beneish M-Score | -2.54 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -1.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.67 |
| EV-to-EBITDA | -2.98 |
| PEG | -- |
| Shares Outstanding M | 81.25 |
| Net Margin (%) | -44.92 |
| Operating Margin % | -35.91 |
| Pre-tax Margin (%) | -49.00 |
| Quick Ratio | 1.23 |
| Current Ratio | 1.47 |
| ROA % (ttm) | -14.75 |
| ROE % (ttm) | -31.94 |
| ROIC % (ttm) | -16.09 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.79 |
MAYNF Number of Guru Trades
MAYNF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MAYNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MAYNF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Mayne Pharma Group Ltd Insider Transactions
No Available Data
News about OTCPK:MAYNF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers